Fusion of the ZNF384 gene as the 3' partner to several different 5' partner genes occurs recurrently in B-cell precursor acute lymphoblastic and mixed phenotype B/myeloid leukemia. These canonical fusions (ZNF384r) contain the complete ZNF384 coding sequence and are associated with a specific gene expression signature. Cases with this signature, but without canonical ZNF384 fusions (ZNF384r-like cases), have been described previously. Although some have been shown to harbor ZNF362 fusions, the primary aberrations remain unknown in a major proportion. We studied 3 patients with the ZNF384r signature and unknown primary genetic background and identified a previously unknown class of genetic aberration affecting the last exon of ZNF384 and resulting in disruption of the C-terminal portion of the ZNF384 protein. Importantly, in 2 cases, the ZNF384 aberration, indel, was missed during the bioinformatic analysis but revealed by the manual, targeted reanalysis. Two cases with the novel aberrations had a mixed (B/myeloid) immunophenotype commonly associated with canonical ZNF384 fusions. In conclusion, we present leukemia cases with a novel class of ZNF384 aberrations that phenocopy leukemia with ZNF384r. Therefore, we show that part of the so-called ZNF384r-like cases represent the same genetic subtype as leukemia with canonical ZNF384 fusions.

Childhood Leukaemia Investigation Prague Prague Czech Republic

Department of Paediatric Haematology and Oncology 2nd Faculty of Medicine Charles University Prague Czech Republic; and

University Hospital Motol Prague Czech Republic

Zobrazit více v PubMed

Gocho Y, Kiyokawa N, Ichikawa H, et al. ; Tokyo Children’s Cancer Study Group . A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia. Leukemia. 2015;29(12):2445-2448. PubMed

Qian M, Zhang H, Kham SK, et al. . Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP. Genome Res. 2017;27(2):185-195. PubMed PMC

Gu Z, Churchman M, Roberts K, et al. . Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia. Nat Commun. 2016;7:13331. PubMed PMC

Hirabayashi S, Ohki K, Nakabayashi K, et al. ; Tokyo Children’s Cancer Study Group (TCCSG) . ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype. Haematologica. 2017;102(1):118-129. PubMed PMC

Liu YF, Wang BY, Zhang WN, et al. . Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia. EBioMedicine. 2016;8:173-183. PubMed PMC

Zaliova M, Stuchly J, Winkowska L, et al. . Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort. Haematologica. 2019;104(7):1396-1406. PubMed PMC

Hirabayashi S, Butler ER, Ohki K, et al. . Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group [published online ahead of print 10 March 2021]. Leukemia. 2021. PubMed PMC

Novakova M, Zaliova M, Fiser K, et al. . DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch. Haematologica. 2021;106(8):2066-2075. haematol.2020.250423. PubMed PMC

Alexander TB, Gu Z, Iacobucci I, et al. . The genetic basis and cell of origin of mixed phenotype acute leukaemia. Nature. 2018;562(7727):373-379. PubMed PMC

Li JF, Dai YT, Lilljebjörn H, et al. . Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases. Proc Natl Acad Sci USA. 2018;115(50):E11711-E11720. PubMed PMC

Gu Z, Churchman ML, Roberts KG, et al. . PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet. 2019;51(2):296-307. PubMed PMC

Li H, Durbin R.. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26(5):589-595. PubMed PMC

Dobin A, Davis CA, Schlesinger F, et al. . STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15-21. PubMed PMC

Koboldt DC, Zhang Q, Larson DE, et al. . VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22(3):568-576. PubMed PMC

Kim D, Salzberg SL.. TopHat-Fusion: an algorithm for discovery of novel fusion transcripts. Genome Biol. 2011;12(8):R72. PubMed PMC

McPherson A, Hormozdiari F, Zayed A, et al. . deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data. PLOS Comput Biol. 2011;7(5):e1001138. PubMed PMC

Roberts KG, Li Y, Payne-Turner D, et al. . Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014;371(11):1005-1015. PubMed PMC